M. C. J. C. Legdeur

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

GJ Ossenkoppele, Georg Stuessi, Yvette van Norden et al. · Leukemia · 2020 · 23 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +7

Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome

Jeroen J. W. M. Janssen, Bob Löwenberg, Markus G. Manz et al. · Leukemia · 2022 · 23 citations · Full text

Medicine, Oncology, Pharmacology +14

G-CSF (filgrastim)-stimulated whole blood kept unprocessed at 4 degrees C does support a BEAM-like regimen in bad-risk lymphoma.

G. J. Ossenkoppele, Gerrit‐Jan Schuurhuis, Andries R. Jonkhoff et al. · PubMed · 1996 · 19 citations

Medicine, Hematology, Oncology +11

High-dose melphalan with re-infusion of unprocessed, G-CFS-primed whole blood is effective and non-toxic therapy in multiple myeloma

G.J. Ossenkoppele, G.J. Schuurhuis, Andries R. Jonkhoff et al. · European Journal of Cancer · 1996 · 12 citations

Medicine, Hematology, Oncology +17

A functional study on the migration of human monocytes to human leukemic cell lines and the role of monocyte chemoattractant protein-1

M. C. J. C. Legdeur, RHJ Beelen, GJ Schuurhuis et al. · Leukemia · 1997 · 12 citations · Full text

Life Sciences, Cell Biology, Oncology +17